Neuropsychological assessment more efficient than MRI for tracking disease progression in memory clinic patients
progression of disease in memory clinic patients can be tracked efficiently with 45 minutes of neuropsychological testing, new research shows. MRI measures of brain atrophy were shown to be less reliable to pick up changes in the same patients. This finding has important implications for the design of clinical trials of new anti-Alzheimer drugs. If neuropsychological assessment is used as the outcome measure or ?gold standard,? fewer patients would be needed to conduct such trials, or the trials may be of shorter duration.
View full story